These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 7460040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)].
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
    Gutterman JU, Mavligit G, McBride C, Frei E, Hersh EM.
    Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319
    [No Abstract] [Full Text] [Related]

  • 7. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
    Calbo L, Gorgone S, Palmeri R, Salibra M, Melita P.
    Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of malignant melanoma (author's transl)].
    Civatte J, Jourdain JC.
    MMW Munch Med Wochenschr; 1978 Mar 24; 120(12):403-6. PubMed ID: 306028
    [Abstract] [Full Text] [Related]

  • 9. [BCG-treatment of malignant melanoma].
    Borberg H.
    Internist (Berl); 1975 Oct 24; 16(10):482-5. PubMed ID: 1107254
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunological changes in cancer patients receiving BCG.
    Cochran AJ, Mackie RM, Jackson AM, Ogg LJ, Ross CE.
    Dev Biol Stand; 1975 Oct 24; 38():441-8. PubMed ID: 608535
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
    MacGregor AB, Falk RE, Landi S, Ambus U, Samuel ES, Langer B.
    Can J Surg; 1977 Jan 24; 20(1):25-30. PubMed ID: 832200
    [Abstract] [Full Text] [Related]

  • 13. The immune response in human malignant melanoma.
    Mackie RM.
    Clin Exp Dermatol; 1976 Mar 24; 1(1):23-8. PubMed ID: 773575
    [No Abstract] [Full Text] [Related]

  • 14. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H, Muth M.
    Z Hautkr; 1982 Feb 15; 57(4):294-7. PubMed ID: 7080583
    [No Abstract] [Full Text] [Related]

  • 15. [Immunologic aspects of the treatment of melanoma].
    Pawlowska EM.
    Pol Tyg Lek; 1977 Jun 13; 32(24):939-41. PubMed ID: 882435
    [No Abstract] [Full Text] [Related]

  • 16. [Immune profil in melanoma patients. III. Behavior of immunglobulins (IgG, IgA, IgM) and of whole complement in serum at the beginning and during BCG-therapy (author's transl)].
    Knopf B, Wätzig V, Stelzner A.
    Arch Geschwulstforsch; 1979 Jun 13; 49(4):299-304. PubMed ID: 496567
    [Abstract] [Full Text] [Related]

  • 17. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS, Mastrangelo MJ, Sulit H, Chee D, Yarbro JW, Prehn LM, Prehn RT.
    Natl Cancer Inst Monogr; 1973 Dec 13; 39():213-20. PubMed ID: 4595320
    [No Abstract] [Full Text] [Related]

  • 18. Immune response and non-specific immunotherapy in melanoma.
    El-Domeiri AA.
    Ann R Coll Surg Engl; 1978 Mar 13; 60(2):117-20. PubMed ID: 637492
    [Abstract] [Full Text] [Related]

  • 19. Results of adjuvant BCG immunotherapy in malignant melanoma.
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1981 Mar 13; 51(6):493-6. PubMed ID: 7332442
    [Abstract] [Full Text] [Related]

  • 20. Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.
    Thatcher N, Crowther D.
    Dev Biol Stand; 1981 Mar 13; 38():449-53. PubMed ID: 608536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.